Bringing diarrhea under CONTROL: dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer

Bibliographic Details
Main Authors:	M. Ruiz-Borrego, A. Chan, G. Marx, A. Brufsky, M. Trudeau, D. Egle, L. McCulloch, D. Tripathy, C.H. Barcenas
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977621000928

Internet